Valuation: Tofflon Science and Technology Group Co., Ltd.

Market Cap 8.99B 1.32B 1.16B 1.06B 991M 1.88B 126B 1.91B 12.77B 4.96B 61.96B 4.97B 4.86B 214B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 5.57B 821M 717M 659M 615M 1.17B 78.14B 1.18B 7.92B 3.08B 38.41B 3.08B 3.01B 132B EV / Sales 2026 *
0.98x
EV / Sales 2027 * 1.26x
Free-Float
25.51%
Yield 2026 *
1.1%
Yield 2027 * 1.86%
05-25 Tofflon Science and Technology Group Co., Ltd. Announces 2025 Final Profit Distribution Plan on A Shares, Payable on June 1, 2026 CI
04-28 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-28 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
25-10-28 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-09-16 Tofflon Science and Technology Group Co., Ltd. Approves Interim Cash Dividend on A Shares for the Year 2025, Payable on September 25, 2025 CI
25-08-28 Tofflon Science and Technology Group Co., Ltd. Proposes Interim Cash Dividend for the Year 2025 CI
25-08-27 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-06-12 Tofflon Science and Technology Group Co., Ltd.(SZSE:300171) dropped from Shenzhen Stock Exchange Component A Share Index CI
25-06-12 Tofflon Science and Technology Group Co., Ltd.(SZSE:300171) dropped from Shenzhen Stock Exchange Component Index CI
25-05-21 Tofflon Science and Technology Group Co., Ltd. Approves Cash Dividend on Share A for 2024 CI
25-04-25 Tofflon Science and Technology Group Co., Ltd. Proposes Final Cash Dividend for the Year 2024 CI
25-04-24 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-04-24 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
1 day+1.37%
1 week+9.66%
Current month+6.78%
1 month+5.73%
3 months-17.24%
6 months-24.78%
Current year-24.78%
1 week 10.42
Extreme 10.42
12.05
1 month 10.42
Extreme 10.42
12.05
Current year 10.42
Extreme 10.42
20.37
1 year 10.42
Extreme 10.42
20.37
3 years 9.6
Extreme 9.6
22.58
5 years 9.6
Extreme 9.6
68
10 years 5.16
Extreme 5.16
68
Manager TitleAgeSince
Chief Executive Officer 62 1992-12-31
Director of Finance/CFO 45 2012-06-30
Corporate Officer/Principal 57 2000-12-31
Director TitleAgeSince
Chairman 62 2008-02-29
Director/Board Member 54 2008-03-29
Director/Board Member 53 2008-03-29
Date Insider Type Main position Quantity % Market Cap.
24-02-04Buy

Chief Executive Officer

40,000 0.0072%
24-01-31Buy

Chief Executive Officer

30,000 0.0054%
24-01-16Buy

Chief Executive Officer

80,000 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
+1.37%+9.66%-9.64%-47.81% 1.32B
-0.10%-0.62%+33.89%+146.26% 121B
+3.19%+5.88%+90.79%+48.72% 43.04B
-0.33%-0.96%-7.35%+23.53% 31.54B
+0.70%+1.10%+49.88%+47.14% 30B
+4.29%+5.82%+45.32%-5.57% 29.67B
-1.59%-5.42%+13.30%+45.24% 28.78B
+0.72%+1.43%-10.70%+5.62% 28.08B
-3.09%-0.91% - - 27.71B
+1.73%+5.29%+44.31%+55.48% 25.23B
Average +0.69%+0.91%+27.76%+35.40% 36.68B
Weighted average by Cap. +0.54%-0.15%+34.86%+72.67%

Financials

2026 *2027 *
Net sales 5.67B 836M 731M 672M 626M 1.19B 79.59B 1.21B 8.06B 3.13B 39.12B 3.14B 3.07B 135B 6.24B 919M 803M 738M 688M 1.31B 87.51B 1.33B 8.86B 3.45B 43.01B 3.45B 3.38B 148B
Net income - -
Net Debt -3.41B -503M -440M -404M -377M -715M -47.9B -725M -4.85B -1.89B -23.55B -1.89B -1.85B -81.14B -1.15B -169M -148M -136M -127M -240M -16.11B -244M -1.63B -634M -7.92B -635M -622M -27.29B
Logo Tofflon Science and Technology Group Co., Ltd.
Tofflon Science and Technology Group Co Ltd is a China-based company mainly engaged in the research, development, production, and sales of pharmaceutical equipment, and the provision of technical services. The Company mainly operates four businesses. The bioprocessing business mainly provides equipment, instruments, and consumables such as fermentation systems, precision packaging systems, and traditional Chinese medicine extraction systems. The pharmaceutical preparations business mainly provides equipment and instruments required for the preparation of injectable dosage forms, oral solid dosage forms, and the inspection and packaging of finished drugs. The integrated engineering solutions business mainly provides information system software and intelligent manufacturing integrated solutions. The food engineering business is mainly engaged in the manufacturing of equipment for the liquid food sector, and the provision of system solutions, process engineering, and overall solutions.
Employees
5,479
Date Price Change Volume
26-07-03 CN¥11.81 +1.37% 11,892,720
26-07-02 CN¥11.65 -0.68% 12,290,697
26-07-01 CN¥11.73 +6.06% 14,852,290
26-06-30 CN¥11.06 -1.78% 7,098,319
26-06-29 CN¥11.26 +4.55% 11,709,398
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
11.81CNY
Average target price
17.00CNY
Spread / Average Target
+43.95%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300171 Stock